1.
Heritability of albumin excretion rate in families of patients with Type II diabetes
by FORSBLOM, C. M
Diabetologia, 1999, Vol.42 (11), p.1359-1366
2.
Risk factors for mortality in Type II (non-insulin-dependent) diabetes : evidence of a role for neuropathy and a protective effect of HLA-DR4
by FORSBLOM, C. M
Diabetologia, 1998, Vol.41 (11), p.1253-1262
3.
Insulin resistance and abnormal albumin excretion in non-diabetic first-degree relatives of patients with NIDDM
by FORSBLOM, C. M
Diabetologia, 1995, Vol.38 (3), p.363-369
4.
Insulin resistance and abnormal albumin excretion in non-diabetic first-degree relatives of patients with NIDDM
by Forsblom, C. M.
Diabetologia, 1995-03, Vol.38 (3), p.363-369
5.
Soluble receptor for AGE (RAGE) is a novel independent predictor of all-cause and cardiovascular mortality in type 1 diabetes
by Thomas, M. C
Diabetologia, 2011-05-24, Vol.54 (10), p.2669-2677
6.
Progression to microalbuminuria in type 1 diabetes: development and validation of a prediction rule
by Vergouwe, Y
Diabetologia, 2010, Vol.53 (2), p.254-262
7.
Early autonomic dysfunction in type 1 diabetes: a reversible disorder?
by Rosengård-Bärlund, M
Diabetologia, 2009-04-02, Vol.52 (6), p.1164-1172
8.
Diabetic nephropathy is associated with low-grade inflammation in Type 1 diabetic patients
by SARAHEIMO, M
Diabetologia, 2003, Vol.46 (10), p.1402-1407
9.
Association between mannose-binding lectin, high-sensitivity C-reactive protein and the progression of diabetic nephropathy in type 1 diabetes
by Hansen, T. K
Diabetologia, 2010-04-16, Vol.53 (7), p.1517-1524
10.
Lipid abnormalities predict progression of renal disease in patients with type 1 diabetes
by Tolonen, N
Diabetologia, 2009-10-10, Vol.52 (12), p.2522-2530
11.
Hyperfiltration in type 1 diabetes: does it exist and does it matter for nephropathy?
by Thomas, M. C
Diabetologia, 2012-02-10, Vol.55 (5), p.1505-1513
12.
Genome-wide association study of urinary albumin excretion rate in patients with type 1 diabetes
by Sandholm, Niina
Diabetologia, 2014-03-05, Vol.57 (6), p.1143-1153
13.
Predicting major outcomes in type 1 diabetes: a model development and validation study
by Soedamah-Muthu, SS
Diabetologia, 2014, Vol.57 (11), p.2304-2314
14.
Receptor for advanced glycation end-products (RAGE) provides a link between genetic susceptibility and environmental factors in type 1 diabetes
by Forbes, J. M
Diabetologia, 2011-02-06, Vol.54 (5), p.1032-1042
15.
Serum Insulin Bioassay Reflects Insulin Sensitivity and Requirements in Type 1 Diabetes
by Janssen, J
The journal of clinical endocrinology and metabolism, 2017, Vol.102 (10), p.3814-3821
16.
Deep breathing improves blunted baroreflex sensitivity even after 30 years of type 1 diabetes
by Rosengård-Bärlund, M
Diabetologia, 2011-05-03, Vol.54 (7), p.1862-1870
17.
Short-term oxygen administration restores blunted baroreflex sensitivity in patients with type 1 diabetes
by Bernardi, L
Diabetologia, 2011-06-07, Vol.54 (8), p.2164-2173
18.
Temporal changes in the frequencies of HLA genotypes in patients with Type 1 diabetes: indication of an increased environmental pressure?
by HERMANN, R
Diabetologia, 2003, Vol.46 (3), p.420-425
19.
Purchase of antidepressant agents by patients with type 1 diabetes is associated with increased mortality rates in women but not in men
by Ahola, A. J
Diabetologia, 2011-10-28, Vol.55 (1), p.73-79
20.
A polymorphism in the gene encoding carnosinase (CNDP1) as a predictor of mortality and progression from nephropathy to end-stage renal disease in type 1 diabetes mellitus
by Alkhalaf, A
Diabetologia, 2010-12, Vol.53 (12), p.2562-2568
